Utah Medical Products
UTMD
87 hedge funds and large institutions have $241M invested in Utah Medical Products in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
74% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 23
6% more funds holding
Funds holding: 82 → 87 (+5)
0% more capital invested
Capital invested by funds: $241M → $241M (+$435K)
0.09% less ownership
Funds ownership: 70.14% → 70.05% (-0.09%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.98M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$1.07M |
| 3 |
PMAM
Penn Mutual Asset Management
Conshohocken,
Pennsylvania
|
+$1.07M |
| 4 |
CYG
Clean Yield Group
Norwich,
Vermont
|
+$884K |
| 5 |
Millennium Management
New York
|
+$749K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$595K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
-$478K |
| 3 |
Renaissance Technologies
New York
|
-$358K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$275K |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$235K |
UTMD Hedge Fund Activity: Q1 2023 in Review
87 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2023, worth a combined $241M — up 0.18% from $241M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new UTMD positions and 2 closed out — a net gain of 6 holders — while 40 added to existing stakes and 23 trimmed.
The largest buyer was Brandes Investment Partners, opening a new position worth an estimated $1.98M. The largest seller was BlackRock, cutting an estimated $595K.
- 87 institutional investors held Utah Medical Products (UTMD) as of Q1 2023, up from 82 in Q4 2022.
- Funds reported $241M of Utah Medical Products stock for Q1 2023, up 0.18% quarter-over-quarter.
- 8 funds opened new Utah Medical Products positions in Q1 2023 and 2 closed out, a net change of +6 holders.
- The largest Utah Medical Products buyer in Q1 2023 was Brandes Investment Partners, an estimated $1.98M added.
- The largest Utah Medical Products seller in Q1 2023 was BlackRock, an estimated $595K sold.
Based on aggregated 13F filings for Q1 2023.